ReviewTherapeutic advances in hematology2017

Midostaurin: a novel therapeutic agent for patients with FLT3-mutated acute myeloid leukemia and systemic mastocytosis.

Molly M Gallogly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.